Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Companyโs business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
์ข
๋ชฉ ์ฝ๋ SLP
ํ์ฌ ์ด๋ฆSimulations Plus Inc
์์ฅ์ผJun 18, 1997
CEOO'Connor (Shawn M)
์ง์ ์212
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJun 18
์ฃผ์800 Park Offices Drive, Suite 401
๋์RESEARCH TRIANGLE PARK
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ27709
์ ํ16617237723
์น์ฌ์ดํธhttps://www.simulations-plus.com/
์ข
๋ชฉ ์ฝ๋ SLP
์์ฅ์ผJun 18, 1997
CEOO'Connor (Shawn M)